GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Icon PLC (NAS:ICLR) » Definitions » Float Percentage Of Total Shares Outstanding

Icon (ICLR) Float Percentage Of Total Shares Outstanding : 99.27% (As of Apr. 25, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Icon Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Icon's float shares is 81.90 Mil. Icon's total shares outstanding is 82.50 Mil. Icon's float percentage of total shares outstanding is 99.27%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Icon's Insider Ownership is 5.23%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Icon's Institutional Ownership is 74.89%.

Icon Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Icon's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=81.90/82.50
=99.27%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Icon (ICLR) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Icon PLC (NAS:ICLR) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
MTD ILMN WAT LH DGX CRL RVTY A EXAS MEDP TSE:2309 TMO DHR IQV IDXX XSWX:LONN SHSE:603259 XPAR:BIM XPAR:ERF NTRA
Traded in Other Exchanges
ICLR:Mexico IJF:Germany
Address
South County Business Park, Leopardstown, Dublin, IRL, D18 X5R3
Website
https://www.iconplc.com
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.